Immune monitoring of transplant patients in transient mixed chimerism tolerance trials.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Human Immunology

• Publication date

  2017-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.humimm.2017.12.011PMID 29289741PMCID PMC5924718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Origin of Enriched Regulatory T Cells in Patients Receiving Combined Kidney–Bone Marrow Transplantation to Induce Transplantation Tolerance

  2017cited by this paper
• Alloimmune T cells in transplantation

  2017cited by this paper
• VpreB serves as an invariant surrogate antigen for selecting immunoglobulin antigen-binding sites

  2016cited by this paper
• Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome

  2016cited by this paper
• Molecular and cellular insights into T cell exhaustion

  2015cited by this paper
• Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients

  2015cited by this paper
• Long‐Term Results in Recipients of Combined HLA‐Mismatched Kidney and Bone Marrow Transplantation Without Maintenance Immunosuppression

  2014cited by this paper
• HLA-mismatched renal transplantation without maintenance immunosuppression.

  2013cited by this paper
• Long-Term Follow-Up of Recipients of Combined Human Leukocyte Antigen-Matched Bone Marrow and Kidney Transplantation for Multiple Myeloma With End-Stage Renal Disease

  2011cited by this paper
• Mechanisms of Donor‐Specific Tolerance in Recipients of Haploidentical Combined Bone Marrow/Kidney Transplantation

  2011cited by this paper
• Acute Renal Endothelial Injury During Marrow Recovery in a Cohort of Combined Kidney and Bone Marrow Allografts

  2011cited by this paper
• Mixed Chimerism, Lymphocyte Recovery, and Evidence for Early Donor-Specific Unresponsiveness in Patients Receiving Combined Kidney and Bone Marrow Transplantation to Induce Tolerance

  2010cited by this paper
• A CD8 T cell-intrinsic role for the calcineurin-NFAT pathway for tolerance induction in vivo.

  2010cited by this paper
• Recipient Dendritic Cells, But Not B Cells, Are Required Antigen‐Presenting Cells for Peripheral Alloreactive CD8+ T‐Cell Tolerance

  2010cited by this paper
• Homeostatic Expansion and Phenotypic Conversion of Human T Cells Depend on Peripheral Interactions with APCs

  2010cited by this paper
• Cutting Edge: Intrathymic Differentiation of Adaptive Foxp3+ Regulatory T Cells upon Peripheral Proinflammatory Immunization

  2010cited by this paper
• Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.

  2009cited by this paper
• Comparison of lung and kidney allografts in induction of tolerance by a mixed-chimerism approach in cynomolgus monkeys.

  2008cited by this paper
• HLA-mismatched renal transplantation without maintenance immunosuppression.

  2008cited by this paper
• The Host Environment Regulates the Function of CD8+ Graft-versus-Host-Reactive Effector Cells1

  2008cited by this paper
• Rapid Deletional Peripheral CD8 T Cell Tolerance Induced by Allogeneic Bone Marrow: Role of Donor Class II MHC and B Cells1

  2008cited by this paper
• The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia.

  2007cited by this paper
• Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine.

  2007cited by this paper
• Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions.

  2006cited by this paper
• Clinical relevance of recipient leukocyte infusion as antitumor therapy following nonmyeloablative allogeneic hematopoietic cell transplantation.

  2006cited by this paper
• Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR.

  2006cited by this paper
• Role of indirect allo- and autoreactivity in anti-tumor responses induced by recipient leukocyte infusions (RLI) in mixed chimeras prepared with nonmyeloablative conditioning.

  2006cited by this paper
• An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues

  2006cited by this paper
• Myeloma Responses and Tolerance Following Combined Kidney and Nonmyeloablative Marrow Transplantation: In Vivo and In Vitro Analyses

  2006cited by this paper
• Mechanisms of the Antitumor Responses and Host-versus-Graft Reactions Induced by Recipient Leukocyte Infusions in Mixed Chimeras Prepared with Nonmyeloablative Conditioning: A Critical Role for Recipient CD4+ T Cells and Recipient Leukocyte Infusion-Derived IFN-γ-Producing CD8+ T Cells1

  2005cited by this paper
• Quantitating Effector and Regulatory T Lymphocytes in Immune Responses by Limiting Dilution Analysis Modeling 1

  2005cited by this paper
• Roles of Deletion and Regulation in Creating Mixed Chimerism and Allograft Tolerance Using a Nonlymphoablative Irradiation-Free Protocol

  2005cited by this paper
• Early regulation of CD8 T cell alloreactivity by CD4+CD25– T cells in recipients of anti‐CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor‐reactive CD8+ T cells, precluding a role for sustained regulation

  2005cited by this paper
• Anti‐tumour response despite loss of donor chimaerism in patients treated with non‐myeloablative conditioning and allogeneic stem cell transplantation

  2005cited by this paper
• Earlier Low‐Dose TBI or DST Overcomes CD8+ T‐Cell‐Mediated Alloresistance to Allogeneic Marrow in Recipients of Anti‐CD40L

  2004cited by this paper
• CD154 Blockade for Induction of Mixed Chimerism and Prolonged Renal Allograft Survival in Nonhuman Primates

  2004cited by this paper
• Graft-versus-host-reactive donor CD4 cells can induce T cell-mediated rejection of the donor marrow in mixed allogeneic chimeras prepared with nonmyeloablative conditioning.

  2004cited by this paper
• Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells.

  2004cited by this paper
• Tolerance in mixed chimerism - a role for regulatory cells?

  2004cited by this paper
• Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism1

  2003cited by this paper
• Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-gamma.

  2003cited by this paper
• Lack of Role for CsA‐Sensitive or Fas Pathways in the Tolerization of CD4 T Cells Via BMT and Anti‐CD40L

  2003cited by this paper
• Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation.

  2003cited by this paper
• Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.

  2003cited by this paper
• Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies.

  2003cited by this paper
• Detection of Suppressor T Lymphocytes and Estimation of Their Frequency in Limiting Dilution Assays by Generalized Linear Regression Modeling

  2003cited by this paper
• Fluctuating lymphocyte chimerism, tolerance and anti-tumor response in a patient with refractory lymphoma receiving nonmyeloablative conditioning and a haploidentical related allogeneic bone marrow transplant.

  2002cited by this paper
• Induction Of Kidney Allograft Tolerance After Transient Lymphohematopoietic Chimerism In Patients With Multiple Myeloma And End-Stage Renal Disease1

  2002cited by this paper
• Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells.

  2002cited by this paper
• Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys1

  2002cited by this paper
• Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.

  2001cited by this paper
• Mechanisms Involved in the Establishment of Tolerance Through Costimulatory Blockade and BMT: Lack of Requirement for CD40L‐Mediated Signaling for Tolerance or Deletion of Donor‐reactive CD4+ Cells

  2001cited by this paper
• Peripheral Deletion After Bone Marrow Transplantation with Costimulatory Blockade Has Features of Both Activation-Induced Cell Death and Passive Cell Death1

  2001cited by this paper
• Induction of tolerance by mixed chimerism with nonmyeloblative host conditioning: the importance of overcoming intrathymic alloresistance.

  2001cited by this paper
• CD4 T Cell-Mediated Alloresistance to Fully MHC-Mismatched Allogeneic Bone Marrow Engraftment Is Dependent on CD40-CD40 Ligand Interactions, and Lasting T Cell Tolerance Is Induced by Bone Marrow Transplantation with Initial Blockade of this Pathway1

  2001cited by this paper
• Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.

  2001cited by this paper
• Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

  2000cited by this paper
• Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.

  2000cited by this paper
• A novel application of cyclosporine A in nonmyeloablative pretransplant host conditioning for allogeneic BMT.

  2000cited by this paper
• Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.

  1999cited by this paper
• Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation.

  1999cited by this paper
• Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.

  1999cited by this paper
• Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses.

  1999cited by this paper
• Tetrameric HLA class I–minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease

  1999cited by this paper
• Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose.

  1998cited by this paper
• Extrathymic T Cell Deletion and Allogeneic Stem Cell Engraftment Induced with Costimulatory Blockade Is Followed by Central T Cell Tolerance

  1998cited by this paper
• Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance.

  1996cited by this paper
• Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.

  1996cited by this paper
• Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.

  1996cited by this paper
• Mixed Allogeneic Chimerism And Renal Allograft Tolerance In Cynomolgus Monkeys

  1995cited by this paper
• Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen.

  1994cited by this paper
• Multiple levels of peripheral tolerance.

  1993cited by this paper
• Effect of natural killer cell depletion on long-term multilineage allogeneic bone marrow engraftment.

  1993cited by this paper
• T Cell Subsets Resisting Induction of Mixed Chimerism Across Various Histocompatibility Barriers

  1993cited by this paper
• Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen

  1989cited by this paper
• Graft-versus-host-related immunosuppression is induced in mixed chimeras by alloresponses against either host or donor lymphohematopoietic cells

  1988cited by this paper
• The role of antigen-presenting cells.

  1983cited by this paper

• Donor Macrophage Depletion Permits Post-Transplant Tolerance Induction in a Murine Islet Transplant Model

  2026cites this paper
• Durable Mixed Chimerism May Permit Subsequent Immunosuppression-Free Intestinal Transplantation - a Proof-of-Principle Study.

  2024cites this paper
• Immune reactions following intestinal transplantation: Mechanisms and prevention.

  2024cites this paper
• Early allogeneic immune modulation after establishment of donor hematopoietic cell-induced mixed chimerism in a nonhuman primate kidney transplant model

  2024cites this paper
• Intestinal Transplant Immunology and Intestinal Graft Rejection: From Basic Mechanisms to Potential Biomarkers

  2023cites this paper
• Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives

  2022cites this paper
• Lung Regeneration by Transplantation of Allogeneic Lung Progenitors Using a Safer Conditioning Regimen and Clinical-grade Reagents

  2022cites this paper
• Cell therapy can enable minimization of immunosuppression

  2020cites this paper
• Deletion of donor‐reactive T cell clones after human liver transplant

  2020cites this paper
• The Adaptome as Biomarker for Assessing Cancer Immunity and Immunotherapy.

  2020cites this paper
• Deletion of donor-reactive T cell clones following human liver transplantation

  2020cites this paper
• Multi-lineage Lung Regeneration by Stem Cell Transplantation across Major Genetic Barriers.

  2020cites this paper
• Outstanding questions in transplantation: Tolerance

  2020cites this paper
• Twenty Year Follow Up of Histocompatibility Leukocyte Antigen-Matched Kidney and Bone Marrow Co-Transplantation for Multiple Myeloma with End Stage Renal Disease: Lessons Learned.

  2019cites this paper
• Clinical transplant tolerance: Coming of age.

  2018cites this paper